Inactive X chromosome epigenetic silencing machinery (Xi silencing machinery)

The inactive X chromosome (Xi) epigenetic silencing machinery is a multi-component system responsible for the transcriptional repression of one X chromosome in females to maintain dosage compensation. This machinery is primarily orchestrated by the long non-coding RNA Xist, which coats the Xi and recruits various repressive factors, including Polycomb Repressive Complex 2 (PRC2), DNA methyltransferases (DNMTs), and histone deacetylases (HDACs) (Bhatnagar et al., 2014). In Rett Syndrome, a neurodevelopmental disorder caused by mutations in the X-linked MECP2 gene, this machinery is a high-priority therapeutic target because females carry a wild-type MECP2 allele that is epigenetically silenced on the Xi. Strategies to reactivate this latent allele involve disrupting the silencing machinery using antisense oligonucleotides (ASOs) against Xist or small-molecule inhibitors of epigenetic enzymes like DNMTs and HDACs (Przanowski et al., 2018; Carrette et al., 2018). Successful reactivation aims to restore functional MECP2 protein levels in the brain, potentially reversing the neurological symptoms of the disease. However, a major challenge is achieving locus-specific reactivation of MECP2 to avoid the toxic effects of global X-linked gene overexpression (Lyst & Bird, 2015). This target represents a novel frontier in precision medicine, moving beyond gene replacement toward the modulation of endogenous epigenetic states.

Other names

X-chromosome inactivation (XCI) machineryXi reactivation machineryMECP2 reactivation complexXist-mediated silencing complex

Inhibition of epigenetic repressors (DNMTs, HDACs, HMTs) and/or degradation of Xist lncRNA to facilitate the transition of the MECP2 locus from heterochromatin to euchromatin on the inactive X chromosome.